Each 1ml contain:
– Amikacin sulfate 333.76 mg
(Equivalent to 250 mg Amikacin base)
Neramecasin
- composition
- properties
- indications
- dosage
- package
- Advantages
Amikacin :
Inhibiting bacterial protein synthesis by binding to 30s ribosomal subunit.
This bound is irreversible (bactericidal)
For the treatment of:
• E.coli
• Pseudomonas spp
• Enterococcus
• other susceptible Gram + ve & Gram – ve bacteria
Route:
• Injectable solution.
Dose:
• 10–12.5 mg/kg B.W.
• Package / 2–2.5 tons B.W.
(Injectable solution. )
– 100 ml
• High efficacy against aminoglycoside-resistant bacteria.
• Excellent lung distribution.
• Lowest toxicity among aminoglycosides.
• Resists bacterial enzyme degradation (making it highly effective against many resistant strains).
• Strong antibacterial effect with minimal nephrotoxicity.
• Wide safety margin with low immunosuppressive impact.
